Blog

Vijaya Diagnostic Centre Limited IPO : Company Information and Financials

Vijaya Diagnostic Centre Limited initiated its operations in 1991. As the name suggests the company is active in the diagnostic business field. Its major business is located in the Southern part of India. The company specialises in Radiology and pathology diagnostic tests. Vijaya Diagnostics also undergoes various package schemes and other medical deals for its corporate and individual customers.

The company has a spread out of more than 80 Diagnostic centres in A.P., Kolkata and Telangana.

IPO DETAILS

Vijaya Diagnostic Centre Limited IPO is set to launch on 1st Sept., 2021. The subscription timeline extends till 3rd Sept., 2021. The size for the IPO is 1895.04 Crore Rs.. Shares issued through Offer for sale are 1895.04 Crore Rs. No Shares are issued through Fresh issue. The minimum lot size is 28 shares and the price is set at 522 Rs. – 531 Rs./ share. The company is going to get listed at both the exchanges NSE and BSE. The face value per share is Re. 1 and this is a book built issue. The registrar for the company is KARVY FINTECH Private Limited.

TABULAR REPRESENTATION OF IPO DETAILS

IPO OPENING DATE	1st Sept., 2021
CLOSING DATE FOR IPO	3rd Sept., 2021
ISSUE TYPE	Book Built Issue
Face Value per share	1 Re. per share
IPO price band	522 Rs. – 531 Rs.
LOT SIZE	28 shares
MINIMUM ORDER QUANTITY	28 shares
ISSUE SIZE	1895.04 Crore Rs.
OFFER FOR SALE	1895.04 Crore Rs.
FRESH ISSUE	No Fresh Issue
LISTING AT	NSE, BSE
LISTING DATE	14th Sept., 2021

IMPORTANT DATES

IPO OPENING DATE	1st Sept., 2021
CLOSING DATE FOR IPO	3rd Sept., 2021
IPO ALLOTMENT DATE	8th Sept., 2021
REFUNDS	9th Sept., 2021
DEMAT A/C CREDITED ON	13th Sept., 2021
IPO LISTING DATE	14th Sept., 2021

The Vijaya Diagnostic Centre Limited IPO begins for subscription from 1st Sept., 2021. The IPO subscription would continue till 3rd Sept., 2021. The allotment status for the shareholders who applied would come on 8th Sept., 2021. The refunds for the ones who did not get allotment would be initiated on 9th Sept., 2021. The DEMAT accounts of shareholders would be credited on 13th Sept., 2021. The listing of the company would be accompanied on 14th Sept., 2021.

Promoters and Lead Managers

The promoter of the company is Dr. Sudernath Reddy.

The lead managers are :

ICICI Securities Limited
Edelweiss Financial Services Limited
Kotak Mahindra Capital Company Limited

The minimum lot size for the company is decided at 28 shares. This holding accounts to 14868 Rs.. The maximum lot size is decided at 364 shares. This amounts to Rs. 193284. Hence the company’s final holdings would be set as :

	Shares	Amount
Minimum	28 shares	14868 Rs
Maximum	364 shares	193284 Rs

OBJECTIVES FOR THE IPO

The money from the IPO can also be utilized to meet general corporate purposes.
Vijaya Diagnostics not only wants to get the listing benefits but also wants to make OFS. Thus by this IPO the purpose of OFS would be done and the holdings by promoters will be diluted to shareholders.

COMPANY FINANCIALS

Particulars (in Million Rs.)	2020-21	2019-20	2018-19
ASSETS	5409	4822	4064
REVENUE	3885	3541	3029
NET PROFIT	849	625	462

Vijaya Diagnostics has been very accurate in the financial track records. The company has not only developed its network of assets over time but also generated significant revenues from it. The asset base for the company was 4050 Crore Rs in 2019 which has increased to 5400 Crore Rs in 2021. This says that the company attained growth of almost 28% in assets in 2 years. This is attracted to the revenue generation of 3000 Crore in 2019 and almost 3900 Crore Rs in 2021. Given the COVID period such a revenue is not very satisfactory. However the company is consistent with the revenue generation.

Keeping aside the COVID growth of revenues, the company has made major progress in generation of profits, The profits improved by almost 97% in 2 years. The profits in 2019 were 462 Crore Rs and they were 849 Crore Rs in 2021. Thus one can opt for the company but on the other hand should be selective with it. If better options are available then one can skip this one out.